Cypher Heart Stent Side Effects and Injuries

The FDA has received numerous reports of blood clotting in patients who received the Cypher heart stent - it is estimated that over 50,000 patients have been implanted with the Cypher stent.

Background:

The FDA approved the Cypher stent in April 2003 for patients undergoing angioplasty procedures to open clogged coronary arteries. The stent is coated with a medication that is designed to keep the arteries from re-clogging after the surgery. The stent is manufactured by Cordis Corporation, a subsidiary of Johnson & Johnson. Since its approval, it is estimated that over 50,000 patients have received a Cypher stent.

In July 2003, Cordis Corporation issued a warning letter to health care professionals informing them of the potential risk of blood clots associated with the use of the Cypher stent. At the time the letter was sent, the FDA had received 47 reports of blood clotting occurring at the time of implantation or within a few days of implantation. Then in October 2003, the FDA announced to physicians that the Cypher stent has been associated with adverse events in patients who received the device. Studies released in 2006 also suggest an increase in the rate of death and heart attacks in patients who received this type of device.

What can I do?

Zimmerman Reed represents local Minnesota man who suffered a heart attack as a result of a blood clot at the site of his Cypher heart stent implant, view the Complaint. If you have experienced any adverse effects from a Cypher heart stent, you should immediately consult your physician. You may also want to consider your potential legal claim. If you would like more information, click here to fill out a free case review form or call attorney Ron Goldser at 800.755.0098. Zimmerman Reed is experienced in handling defective medical device cases and we welcome any questions you may have.